Facebook Linkedin RSS Twitter Youtube
Home 2024

Preclinical development

Sibylla Biotech and MD Anderson Agree to Jointly Discover and Develop Small-Molecule Protein Degraders
Drug Discovery

Sibylla Biotech and MD Anderson Agree to Jointly Discover and Develop Small-Molecule Protein Degraders

Machine Learning Digs Up a Treasure Trove of Antimicrobial Peptides
Artificial Intelligence

Machine Learning Digs Up a Treasure Trove of Antimicrobial Peptides

Finding “Impossible” Antibodies in the Human Body
Drug Discovery

Finding “Impossible” Antibodies in the Human Body

Mitigating Risks in Oligonucleotide Therapeutic Development
Sponsored

Mitigating Risks in Oligonucleotide Therapeutic Development

Wacker Expands its San Diego Facility’s Production Capacity
Bioprocessing

Wacker Expands its San Diego Facility’s Production Capacity

Antibody-Drug Conjugate Slays Cancerous T Cells, Spares Many Normal T Cells
Cancer

Antibody-Drug Conjugate Slays Cancerous T Cells, Spares Many Normal T Cells

New Mouse Models Improve the Accuracy of Preclinical Studies
Drug Discovery

New Mouse Models Improve the Accuracy of Preclinical Studies

PROTAC Drug Candidates Could Offer Up Strategy for Eliminating HIV Reservoir
Featured

PROTAC Drug Candidates Could Offer Up Strategy for Eliminating HIV Reservoir

Pancreatic Cancer Drug Candidate Targets Elusive, but Common, K-Ras Variant
Cancer

Pancreatic Cancer Drug Candidate Targets Elusive, but Common, K-Ras Variant

Chronic Pain Treatments Could Target Ion Channel Implicated in Touch Perception
Featured

Chronic Pain Treatments Could Target Ion Channel Implicated in Touch Perception

123...45Page 1 of 45
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.